(5S)-1-[(4-chlorophenyl)-(6-piperidin-1-yl-3-pyridinyl)methyl]-5-[3-(trifluoromethyl)phenyl]imidazolidin-2-one

C27H26ClF3N4O — CID 69045205

IUPAC(5S)-1-[(4-chlorophenyl)-(6-piperidin-1-yl-3-pyridinyl)methyl]-5-[3-(trifluoromethyl)phenyl]imidazolidin-2-one
SMILESO=C1NC[C@H](c2cccc(C(F)(F)F)c2)N1C(c1ccc(Cl)cc1)c1ccc(N2CCCCC2)nc1
InChIInChI=1S/C27H26ClF3N4O/c28-22-10-7-18(8-11-22)25(20-9-12-24(32-16-20)34-13-2-1-3-14-34)35-23(17-33-26(35)36)19-5-4-6-21(15-19)27(29,30)31/h4-12,15-16,23,25H,1-3,13-14,17H2,(H,33,36)/t23-,25?/m1/s1
InChIKeyCNUKHZQDAILYJY-XQZUBTRRSA-N
MW514.98 g/mol
LogP6.60
Rot. Bonds5

About (5S)-1-[(4-chlorophenyl)-(6-piperidin-1-yl-3-pyridinyl)methyl]-5-[3-(trifluoromethyl)phenyl]imidazolidin-2-one

(5S)-1-[(4-chlorophenyl)-(6-piperidin-1-yl-3-pyridinyl)methyl]-5-[3-(trifluoromethyl)phenyl]imidazolidin-2-one (PubChem CID 69045205) has the molecular formula C27H26ClF3N4O and a molecular weight of 514.98 g/mol. Its IUPAC name is (5S)-1-[(4-chlorophenyl)-(6-piperidin-1-yl-3-pyridinyl)methyl]-5-[3-(trifluoromethyl)phenyl]imidazolidin-2-one.

Molecular Properties

Compound Name(5S)-1-[(4-chlorophenyl)-(6-piperidin-1-yl-3-pyridinyl)methyl]-5-[3-(trifluoromethyl)phenyl]imidazolidin-2-one
PubChem CID69045205
Molecular FormulaC27H26ClF3N4O
Molecular Weight514.98 g/mol
Exact Mass514.17
IUPAC Name(5S)-1-[(4-chlorophenyl)-(6-piperidin-1-yl-3-pyridinyl)methyl]-5-[3-(trifluoromethyl)phenyl]imidazolidin-2-one
SMILESO=C1NC[C@H](c2cccc(C(F)(F)F)c2)N1C(c1ccc(Cl)cc1)c1ccc(N2CCCCC2)nc1
InChIInChI=1S/C27H26ClF3N4O/c28-22-10-7-18(8-11-22)25(20-9-12-24(32-16-20)34-13-2-1-3-14-34)35-23(17-33-26(35)36)19-5-4-6-21(15-19)27(29,30)31/h4-12,15-16,23,25H,1-3,13-14,17H2,(H,33,36)/t23-,25?/m1/s1
InChIKeyCNUKHZQDAILYJY-XQZUBTRRSA-N
XLogP6.60
TPSA48.47 Ų
H-Bond Donors1
H-Bond Acceptors3
Rotatable Bonds5
Heavy Atoms36
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500514.98
LogP ≤ 56.60
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 103

Analyze (5S)-1-[(4-chlorophenyl)-(6-piperidin-1-yl-3-pyridinyl)methyl]-5-[3-(trifluoromethyl)phenyl]imidazolidin-2-one with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of (5S)-1-[(4-chlorophenyl)-(6-piperidin-1-yl-3-pyridinyl)methyl]-5-[3-(trifluoromethyl)phenyl]imidazolidin-2-one?
The IUPAC name of (5S)-1-[(4-chlorophenyl)-(6-piperidin-1-yl-3-pyridinyl)methyl]-5-[3-(trifluoromethyl)phenyl]imidazolidin-2-one (CID 69045205) is (5S)-1-[(4-chlorophenyl)-(6-piperidin-1-yl-3-pyridinyl)methyl]-5-[3-(trifluoromethyl)phenyl]imidazolidin-2-one.
What is the SMILES notation for (5S)-1-[(4-chlorophenyl)-(6-piperidin-1-yl-3-pyridinyl)methyl]-5-[3-(trifluoromethyl)phenyl]imidazolidin-2-one?
The canonical SMILES for (5S)-1-[(4-chlorophenyl)-(6-piperidin-1-yl-3-pyridinyl)methyl]-5-[3-(trifluoromethyl)phenyl]imidazolidin-2-one is O=C1NC[C@H](c2cccc(C(F)(F)F)c2)N1C(c1ccc(Cl)cc1)c1ccc(N2CCCCC2)nc1.
What is the InChIKey of (5S)-1-[(4-chlorophenyl)-(6-piperidin-1-yl-3-pyridinyl)methyl]-5-[3-(trifluoromethyl)phenyl]imidazolidin-2-one?
The InChIKey is CNUKHZQDAILYJY-XQZUBTRRSA-N. The full InChI is InChI=1S/C27H26ClF3N4O/c28-22-10-7-18(8-11-22)25(20-9-12-24(32-16-20)34-13-2-1-3-14-34)35-23(17-33-26(35)36)19-5-4-6-21(15-19)27(29,30)31/h4-12,15-16,23,25H,1-3,13-14,17H2,(H,33,36)/t23-,25?/m1/s1.
What are the key properties of (5S)-1-[(4-chlorophenyl)-(6-piperidin-1-yl-3-pyridinyl)methyl]-5-[3-(trifluoromethyl)phenyl]imidazolidin-2-one?
(5S)-1-[(4-chlorophenyl)-(6-piperidin-1-yl-3-pyridinyl)methyl]-5-[3-(trifluoromethyl)phenyl]imidazolidin-2-one has a molecular weight of 514.98 g/mol, XLogP of 6.60, 5 rotatable bonds, 1 hydrogen bond donors, and 3 hydrogen bond acceptors.
Where does this data come from?
All data for (5S)-1-[(4-chlorophenyl)-(6-piperidin-1-yl-3-pyridinyl)methyl]-5-[3-(trifluoromethyl)phenyl]imidazolidin-2-one is sourced from PubChem (CID 69045205), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).